Breast cancer is a heterogeneous disease and has been classified into several molecular subtypes, including basal-like, HER2-positive, and luminal breast cancers (Perou et al., 2000; Sørlie et al., 2001). This evidence concerns the gene ERBB2 and breast carcinoma.